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Introduction
The glomerular filtration barrier allows the efficient flow of water and small molecules while preventing 
plasma proteins from leaking into the urine. The barrier consists of  podocytes, endothelial cells, and the glo-
merular basement membrane (GBM). Nephrotic syndrome, characterized by proteinuria, edema, hypoalbu-
minemia, and hyperlipidemia, is associated with impaired glomerular filtration. Nephrotic syndrome can be 
caused by dysfunctions of  podocytes, endothelial cells, or GBM, indicating that all 3 components are essential 
for maintaining the glomerular filtration barrier. Extensive genetic studies of  nephrotic syndrome have identi-
fied mutations in genes important for establishing and maintaining the barrier (1).
The GBM is a specialized extracellular matrix separating 2 cellular layers, endothelial cells and podocytes. 
The GBM plays critical roles in filtration and in maintenance of glomerular morphology (2). Basement mem-
brane (BM) is usually composed of 4 major extracellular matrix proteins: laminin, collagen IV, nidogen, and 
sulfated proteoglycan. The GBM contains an atypical assortment of BM protein isoforms, including collagen 
α3α4α5(IV) and laminin-521 (LM521; α5β2γ1; ref. 3). Mutations in collagen α3α4α5(IV) cause Alport syndrome, 
a kidney disease with variable ear and eye defects (4). LM521 is composed of α5, β2, and γ1 chains. Muta-
tions in the laminin β2 gene (LAMB2) cause Pierson syndrome, which is characterized by congenital nephrotic 
Mutations in LAMB2, encoding laminin β2, cause Pierson syndrome and occasionally milder 
nephropathy without extrarenal abnormalities. The most deleterious missense mutations that 
have been identified affect primarily the N-terminus of laminin β2. On the other hand, those 
associated with isolated nephropathy are distributed across the entire molecule, and variants  
in the β2 LEa-LF-LEb domains are exclusively found in cases with isolated nephropathy. Here we 
report the clinical features of mild isolated nephropathy associated with 3 LAMB2 variants in the 
LEa-LF-LEb domains (p.R469Q, p.G699R, and p.R1078C) and their biochemical characterization. 
Although Pierson syndrome missense mutations often inhibit laminin β2 secretion, the 3 
recombinant variants were secreted as efficiently as WT. However, the β2 variants lost pH 
dependency for heparin binding, resulting in aberrant binding under physiologic conditions.  
This suggests that the binding of laminin β2 to negatively charged molecules is involved in 
glomerular basement membrane (GBM) permselectivity. Moreover, the excessive binding of the 
β2 variants to other laminins appears to lead to their increased deposition in the GBM. Laminin 
β2 also serves as a potentially novel cell-adhesive ligand for integrin α4β1. Our findings define 
biochemical functions of laminin β2 variants influencing glomerular filtration that may underlie 
the pathogenesis of isolated nephropathy caused by LAMB2 abnormalities.
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syndrome with severe ocular and neuromuscular defects (5). Zenker et al. originally identified homozygous 
or compound heterozygous mutations in the LAMB2 gene, which contains 32 exons, in patients with Pierson 
syndrome (6). More than 49 mutations have since been reported to be associated with Pierson syndrome (5). 
Most disease-associated alleles are truncating mutations localized across the entire gene, eliminating laminin β2 
function completely (7). On the other hand, the patients with LAMB2 missense mutations occasionally exhibit 
higher mean age at onset of renal disease or oligosymptomatic disease variants of Pierson syndrome (5). For 
example, p.R246Q and p.R246W lead to congenital or infantile nephrotic syndrome with milder or no extra-
renal symptoms (5, 6). A patient with Pierson syndrome carrying p.S80R presented with late-onset nephrotic 
syndrome that was diagnosed when the patient was 6.5 years old (5). Another missense mutation, p.C321R, is 
associated with congenital nephrotic syndrome, despite less severe extrarenal defects (5). p.C321R affects the 
formation of disulfide bonds in an EGF-like module and disrupts the structure of the LEa domain, leading to 
defective secretion of laminin β2 and podocyte ER stress possibly due to misfolding of the aberrant laminin β2 
(8). Previously, Matejas et al. demonstrated that missense mutations found in Pierson syndrome are apparently 
clustered in the laminin N-terminal (LN) domain, which is required for the polymerization of laminins (5). 
Therefore, mutations in the LN domain have been implicated in the perturbation of BM formation.
Laminin is a family of  heterotrimeric glycoproteins that mediate cell adhesion via various receptors. Five 
α, 3 β, and 3 γ chains have been characterized, and 19 isoforms have been identified in various tissues and 
cell culture media (9). Of the isoforms, 9 contain laminin β2, and LM521 is the most studied of  these. LM521 
trimers are recognized by several receptors, including integrin α3β1, α6β1, and α6β4; α-dystroglycan; and Luther-
an/basal cell adhesion molecule. The C-terminal 20–amino acid sequence of  the laminin β2 chain modu-
lates the binding affinities of  laminins to X2-type integrins, such as α3β1 and α7X2β1 (10). However, because 
the laminin globular domains of  laminin α chains have been implicated in various cellular interactions, the 
X2-type integrins are not specific for laminin β2. The β2 chain of  laminin-421 and -521 are also identified as 
ligands that bind to N- and P/Q-type voltage-gated calcium channels (VGCCs, ref. 11). Although VGCCs 
specifically bind to laminin β2 at neuromuscular junction presynaptic terminals, it is unlikely that these medi-
ate cell adhesion to the β2 chain. So far, the cell-adhesive activity of  laminin β2 has not been fully examined.
Next-generation sequencing approaches have also identified LAMB2 missense mutations in congeni-
tal or childhood-onset nephrotic syndrome without apparent extrarenal abnormalities (12–19). Here we 
demonstrate that most of  these missense variants found in cases with isolated nephropathy affect a region 
in the LEa-LF-LEb domains in the laminin β2 short arm. Notably, variants in this region have not been 
found in patients with classic Pierson syndrome. We examined the effects of  these variants on secretion 
of  laminin β2 in vitro. To explore the biochemical properties that might influence glomerular filtration, 
recombinant laminin β2 chains carrying the variants were produced in mammalian cells. We found that 
laminin β2 serves as a potentially novel cell-adhesive ligand for integrin α4β1. These results unraveled roles 
of  the laminin β2 short arm in matrix regulation that may underlie the pathogenesis of  isolated nephropa-
thy as a mild form of  Pierson syndrome.
Results
We previously reported a Japanese patient with isolated nephropathy carrying LAMB2 p.R469Q and p.G699R 
variants (12). He was born to a healthy parent and appeared normal at birth. He exhibited systemic edema by 
21 months and was diagnosed with steroid-resistant nephrotic syndrome. A kidney biopsy at 23 months of age 
revealed focal segmental glomerulosclerosis (FSGS) and mesangial matrix expansion (Supplemental Figure 
1A; supplemental material available online with this article; https://doi.org/10.1172/jci.insight.145908DS1). 
As seen by electron microscopy, the GBM exhibited a stratified structure (Supplemental Figure 1B). The 
patient’s renal function declined and progressed to end-stage kidney disease (ESKD) at 26 months of age. After 
renal transplantation at 7 years of age, he is presently healthy without extrarenal symptoms. Our whole-exome 
analyses of the patient and his parents showed that c.1406G>A (p.R469Q) and c.2095G>C (p.G699R) in 
LAMB2 are derived from his father and mother, respectively (Supplemental Figure 2, A and B, and ref. 12). 
The former, c.1406G>A (p.R469Q), has not been reported in Genome Aggregation Database (gnomAD) (20) 
or TogoVar (21). Although c.1406G is adjacent to a splice acceptor site, the predictions of bioinformatics tools 
such as NNSplice and ASSP (22, 23) were comparable to that of WT (Supplemental Figure 2C), suggesting 
that c.1406G>A does not influence splicing. The allele frequency of c.2095G>C (p.G699R) is 0.01173 in East 
Asians (gnomAD) and 0.007 in 2 Japanese genome databases (ToMMo 4.7KJPN and GEM-J WGA; available 
from TogoVar, ref. 21, and Supplemental Table 1).
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A Hispanic patient was found to have massive proteinuria by 20 months and diagnosed with steroid-re-
sistant nephrotic syndrome. Sanger sequencing identified a heterozygous c.3232C>T (p.R1078C) variant 
in LAMB2; its allele frequency is 0.000276 (gnomAD). Additional pathogenic variants were not identified 
in LAMB2 or in genes associated with early-onset nephrotic syndrome in this patient, but we suspect there 
is an additional pathogenic variant in LAMB2 that could not be identified. In silico algorithms (SIFT, Poly-
Phen-2, Align-GVGD) suggested that p.R1078C is likely to be disruptive (24–26). In the ClinVar database 
(27) there are multiple submissions of  this variant in nephrotic syndrome or Pierson syndrome but with 
scarce clinical or genetic information.
Including these cases, 14 cases carrying LAMB2 variants that presented with nephropathy without ocu-
lar or neurologic abnormalities have been reported in the literature (Table 1). These patients presented 
with abnormal urinalysis to varying degrees, ranging from mild hematuria to nephrotic range proteinuria. 
Among the patients, 4 of  their cases progressed to ESKD in the infantile period (cases 2, 3) or in early 
childhood (cases 4, 5). Other cases maintained normal kidney function in childhood and even at school 
age. This feature is quite different from the clinical picture of  typical Pierson syndrome, in which patients 
often progress to ESRD in the early infantile period. With respect to genetic involvement, 1 patient (case 
14) carries splice site variants in LAMB2, and the other patients carry at least 1 missense variant. These 
missense variants are distributed in exons 2–29 (Figure 1A). This is in clear contrast to missense mutations 
found in typical patients with Pierson syndrome, which cluster in exons 2–9 and 25–28. Missense variants 
in a region spanning from exon 10 to 24, which encode the LEa-LF-LEb domains in the laminin β2 short 
arm, were found in 9 patients (64.3%) with isolated nephropathy (cases 4–13), despite the mutations in that 
region not being reported in previously reported classical Pierson syndrome patients with ocular or neuro-
logical manifestations (Supplemental Table 2). Furthermore, none of  these 9 patients progressed to ESRD 
in the infantile period. Therefore, we hypothesized that variants in this region may be associated with the 
mild phenotype caused by LAMB2 abnormalities.
Secretion of  laminin β2 short arm carrying p.R469Q, p.G699R, and p.R1078C in vitro. To examine the impact 
of missense variants in the LEa-LF-LEb domains of the laminin β2 short arm, we searched for associated 
functional alterations. We chose 3 variants found in our patients, p.R469Q, p.G699R, and p.R1078C, affecting 
the LEa, LF, and LEb domains, respectively (Figure 1A). Although Arg469 and Gly699 are highly conserved 
among species, Arg1078 is replaced with His in the rhesus monkey and mouse (Figure 1B). Our previous study 
showed that some laminin β2 mutations result in impaired secretion (28). Therefore, we investigated whether 









Biopsy findings Ethnicity Publications
1 p.D53N p.R464H c.hetero 8 mo 1 y FSGS Chinese 17
2 p.R246Q p.R246Q homo 1 mo <1 y (expired at 5 y) FSGS Turkish 16
3 p.R246Q p.R246Q homo <1 mo <1 y NA Turkish 16
4 p.L274P p.L274P homo 2 y 3 y Mesangial proliferation Japanese 13
5 p.R469Q p.G699R c.hetero 1 y 2 y FSGS Japanese 12
6 p.F560I p.P1024L c.hetero 10 y Expired by ESRD IgM nephropathy Pakistani 18
7 p.R644H p.G1623D c.hetero 0.8 y 4 y FSGS European 19
8 p.G699R p.Y76Tfs c.hetero 1 mo 3 y Mesangial proliferation Japanese 13
9 p.G699R p.Y76Tfs c.hetero 6 mo 7 y Mesangial proliferation Japanese 13
10 p.I992V p.R1148H c.hetero 12 y FSGS Pakistani 18
11 p.Q1048H p.Q1048H homo 13.5 y FSGS Pakistani 18
12 p.R1078C Not identified c.hetero 20 mo DMS Hispanic This study
13 p.A1556V p.A1556V homo 1 y FSGS Pakistani 18
14 p.Q1692Vfs c.3797+5G c.hetero NA 5 y TBM, BWC Japanese 13
ARenal function is maintained until at least the stated age. FSGS, focal segmental glomerulosclerosis; ESRD, end-stage renal disease; DMS, diffuse 
mesangial sclerosis; TBM, thin BM; BWC, basket weave change. 
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the 3 β2 mutations influenced the secretion of laminin β2 by expressing N-terminal fragments of rat β2 mutants 
in HEK293 cells using a system in which the β2 short arm was fused to a human immunoglobulin Fc domain 
(Figure 2A). As shown in our previous study, although the p.C321R mutant was synthesized in the trans-
fectants, its secretion was impaired (Figure 2, B and C). In contrast, the p.R469Q, p.G699R, and p.R1078C 
mutant fusion proteins were secreted into the medium similarly to the WT fusion protein. These results indi-
cate that these 3 variants did not inhibit LM521 secretion.
Heparin binding properties of  mutant laminin β2 short arms. Lamb2-knockout mice exhibit mislocalized 
anionic sites in the GBM, indicating that laminin β2 is associated with negative charge either directly or 
indirectly (29). The negative charge of  the GBM is mainly imparted by heparan sulfate chains of  the pro-
teoglycan agrin (30, 31). Based on the known locations of  both the laminin binding site and the glycosami-
noglycan (GAG) attachment sites on agrin, together with super-resolution imaging data (32), the laminin 
β2 short arm could be capable of  interacting with agrin’s negatively charged GAG side chains. Therefore, 
we investigated whether the laminin β2 variants bound to heparan sulfate using recombinant proteins. We 
purified recombinant rat laminin β2 short arms carrying the variants fused with human IgG1 Fc from con-
ditioned media (Figure 3A). Human IgG1 Fc and mouse laminin β1 short arm fused with human IgG1 Fc 
were prepared as control proteins. SDS-PAGE analysis of  the purified proteins revealed a single protein 
band corresponding to the expected size. Heparin, a highly sulfated form of  heparan sulfate, was used for 
solid phase binding assays. Heparin acts as a cation exchanger because of  its polyanionic features and can 
bind to cationic proteins in an ion strength–dependent manner. Whereas both WT and mutant laminin β2 
short arms bound to heparin at low ionic strength, only the mutant forms bound under physiologic ionic 
conditions (Figure 3B). These results indicated that the variants increased the binding of  laminin β2 to hep-
arin under physiologic conditions. Our results also show that laminin β1 did not bind heparin, indicating 
that heparin binding is a characteristic feature of  the β2 chain.
To narrow the heparin binding region on the laminin β2 short arm, we produced truncated recombinant 
fragments (Figure 4, A and B). Solid phase binding assays were performed under low ionic conditions. Hepa-
rin bound to laminin β2 LN-LEa domains, indicating the heparin binding region is localized in the N-terminus 
Figure 1. LAMB2 variants. (A) The missense variants found in isolated nephropathy (upper arrowheads, Table 1) and Pierson syndrome (lower arrowheads, 
Supplemental Table 2). Vertical bars and horizontal lines represent exons and introns of the human LAMB2 gene, respectively. Numerals indicate exon 
numbers. p.R469Q, p.G699R, and p.R1078C are indicated by red arrows. Boxes indicate the domain structure of laminin β2. (B) Amino acid sequence align-
ments of laminin β2 derived from multiple species.
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(Figure 4C). These results suggest that the variants structurally influence the heparin binding affinity of  the 
N-terminus under physiologic conditions rather than providing additional heparin binding sites. We next 
examined the heparin binding of  trimeric laminins and found that under low ionic conditions, LM521 con-
taining the β2 chain bound heparin significantly stronger than did laminin-511 containing the β1 chain (Figure 
4D). There was no difference in heparin binding under physiologic conditions. These results indicate that 
laminin β2 influences heparin-binding properties of  the whole laminin trimer.
Although heparin bound to laminin β2 at low ionic strength, it is unlikely that there are low-salt conditions 
in vivo. Another factor that can modulate the charge of  laminin β2 for heparin binding is the concentration 
of  hydrogen ion (pH). To explore this, we first calculated the theoretical isoelectric point (pI) of  each domain 
based on amino acid sequence (Figure 5A and Supplemental Figure 3). Of the laminin β2 domains, the pI 
of  the LN domain was more than 7.4, which is the physiologic pH in blood. On the other hand, each pI of  
laminin β1 domains exhibited acidity. These results suggest that the laminin β2 LN domain has more positive 
charge under acidic conditions. Therefore, solid phase binding assays were performed under different pH con-
ditions (Figure 5B). Heparin binding to the laminin β2 short arm was enhanced at pH = 6.1 versus pH = 7.1. 
These results indicate that laminin β2 modulates GBM charge in a pH-dependent manner.
The binding of  laminin β2 variants to laminin-111. Laminins polymerize to form a network in BMs. The 
polymerization of  laminins is mediated by the 3 short arms of  the cross-shaped heterotrimer (33). The short 
arms are capped with LN domains that mediate the interactions among laminin trimers. To investigate the 
interaction of  mutant laminin β2 short arms with other laminins, solid phase binding assays were performed 
using laminin-111 (Figure 6A). Laminin β2 mutants readily bound to laminin-111, but the WT β2 short arm 
did not bind at this concentration (64 nM). The binding of  β1 and β2 LN domains to laminin-111 was also 
Figure 2. Secretion of laminin β2 variants in vitro. (A) Schematic diagrams of laminin β2 domains. Two-way arrows indi-
cate positions of the missense variants in LEa, LF, and LEb domains. The β2 short arm carrying the variants was fused 
with an Fc-tag (B2SA_Fc). (B) Immunoblot analysis of WT and mutant laminin β2 short arm/Fc fusion proteins in lysates 
of HEK293 cells (left panel). Cell lysates of negative control (lane 1), B2SA_Fc (WT, lane 2), B2SA_C321R_Fc (p.C321R, lane 
3), B2SA_R469Q_Fc (p.R469Q, lane 4), B2SA_G699R_Fc (p.G699R, lane 5), and B2SA_R1078C_Fc (p.R1078C, lane 6) were 
analyzed by immunoblot under reducing conditions. The recombinant proteins were detected using anti-human IgG Fc 
antibody as described in Methods. β-Actin (ACTB) was used as internal control (right panel). The variant proteins were 
expressed in the transfectants similar to WT. (C) Immunoblot analysis of WT and variant proteins in conditioned media 
of HEK293 cells. The variant proteins carrying R469Q, G699R, and R1078C were secreted with efficiency similar to WT.
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observed at higher concentration (128 nM), indicating that they bound less robustly than did the mutants 
(Supplemental Figure 4). Divalent cations such as Ca2+ are required for self-polymerization of  laminins (33). 
To investigate the manner of  laminin-111 binding, we also performed solid phase binding assays in the pres-
ence of  EDTA (Figure 6B). Chelation of  divalent cations significantly enhanced laminin-111 binding rather 
than inhibiting it. That the laminin β2 short arm bound to laminin-111 in a divalent cation-independent man-
ner suggests that the variants unmask a novel laminin binding site.
Adhesion of  HEK293 cells to the laminin β2 short arm in vitro. The heparin binding activity of  laminin β2 led 
us to hypothesize that it binds to cell surface receptors containing heparan sulfate such as syndecans and glyp-
icans. We therefore explored the cell adhesion activity of  the laminin β2 short arm. HEK293 cells suspended 
Figure 3. Solid phase binding assays of heparin to immobilized mutant laminin β2 short arm. (A) Variant laminin β2 short arm/Fc fusion proteins. Fc 
(lane 1), B1SA_Fc (β1 short arm, lane 2), B2SA_Fc (WT β2 short arm, lane 3), B2SA_R469Q_Fc (p.R469Q, lane 4), B2SA_G699R_Fc (p.G699R, lane 5), and 
B2SA_R1078C_Fc (p.R1078C, lane 6) purified from conditioned media of the transfectants were subjected to SDS-PAGE on a 5%–15% gel under reducing 
conditions. (B) Heparin binding of mutant laminin β2 protein in 10 mM Tris-HCl (pH 7.5) with 0 mM NaCl (upper panel), 150 mM NaCl (middle panel), and 
500 mM NaCl (lower panel). Ninety-six-well microtiter plates were coated with 10 μg/mL of recombinant proteins. After blocking, the wells were incubated 
with 10 μg/mL of biotinylated heparin for 1 hour at room temperature. The recombinant Fc protein was used as control. The bound heparin was detected 
with horseradish peroxidase–conjugated streptavidin. Box-and-whisker plots show median, 25th and 75th percentiles, and minimum and maximum val-
ues (n = 6 from 3 independent experiments). Data were analyzed by 1-way ANOVA with Tukey’s multiple-comparison test, *P < 0.001.
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in serum-free DMEM were plated on wells coated with the recombinant proteins. The cells weakly adhered 
to the laminin β2 LN-LEa domains but not to the full β2 short arm (Figure 7A). Based on the heparin binding 
at low ionic strength, the cell adhesion assay was next performed in diluted DMEM. The low ionic strength 
markedly promoted cell adhesion not only to the laminin β2 LN-LEa domains but also to the β2 short arm. 
The cells readily adhered to the laminin β2 LN-LEa domains, indicating that the cell attachment site is local-
ized in the N-terminus. The laminin β2 mutants were more cell adhesive than the WT β2 short arm (Figure 
7B). Thus, similar to heparin binding, the variants appeared to structurally influence cell-adhesive activity of  
the laminin β2 N-terminus. Furthermore, to clarify the mechanism of cell adhesion, we identified the recep-
tors’ binding to the laminin β2 N-terminus. Although cell surface receptors carrying heparan sulfate were 
initially expected, the cell adhesion assays revealed divalent cation dependency, indicating the involvement 
of  integrins. Cell adhesion assays were performed in the presence of  function-blocking antibodies to integrins 
(Figure 7C). Anti–integrin β1 and α4 monoclonal antibodies significantly inhibited the adhesion of  HEK293 
cells to laminin β2 LN-LEa domains, indicating that the cell adhesion is mediated by integrin α4β1.
Figure 4. Characterization of heparin binding to the laminin β2 short arm. (A) Schematic diagrams of truncated laminin β1 and β2 short arms fused with 
an Fc-tag. (B) SDS-PAGE analysis of B1SA_Fc (β1 short arm, lane 1), B1LN-LEa_Fc (lane 2), B2SA_Fc (β2 short arm, lane 3), and B2LN-LEa _Fc (lane 4). (C) 
Heparin binding of β chain LN-LEa domains in 10 mM Tris-HCl (pH 7.5). Ninety-six-well microtiter plates were coated with 10 μg/mL of recombinant proteins. 
After blocking, 10 μg/mL of biotinylated heparin was applied to the wells and incubated for 1 hour at room temperature. The bound heparin was detected 
as described in Methods. Box-and-whisker plots show median, 25th and 75th percentiles, and minimum and maximum values (n = 6 from 3 independent 
experiments). Data were analyzed by 1-way ANOVA with Tukey’s multiple-comparison test, *P < 0.001. (D) The binding of heparin to whole laminin contain-
ing β2 chain in 10 mM Tris-HCl (pH 7.5), without (left panel) or with 150 mM (right panel) NaCl. Ninety-six-well microtiter plates were coated with laminin-111 
(LM111), laminin-511 (LM511), and laminin-521 (LM521) at 10 μg/mL. Data were analyzed by 1-way ANOVA with Tukey’s multiple-comparison test, *P < 0.001 
and are shown as box-and-whisker plots (n = 6 from 3 independent experiments).
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Discussion
Recently, variants in LAMB2 have been found in patients with nephropathy but without apparent extrarenal 
manifestations. These cases also present with less severe renal phenotypes. Proteinuria is often found in child-
hood, and some cases maintain renal function in adolescence, which is a clear contrast to the clinical course 
of  typical Pierson syndrome. Electron microscopic analysis of  kidneys of  these patients demonstrated a thin 
or stratified GBM forming a basket weave pattern (Supplemental Figure 1 and ref. 13). Notably, laminin 
β2 in the GBM from a proteinuric patient carrying compound heterozygous truncating (p.Y76TfsTer) and 
missense (p.G699R) variants was detected (13), indicating that p.G699R did not cause a secretion defect. We 
noted that the distribution of  missense variants causing Pierson syndrome and those of  isolated nephropathy 
were different: variants in a region spanning from exon 10 to exon 24, which correspond to the LEa-LF-LEb 
domains in the laminin β2 short arm, were exclusively found in patients with isolated nephropathy. Although 
it is known that LN domains mediate the self-polymerization of  laminins, the functions of  the LEa-LF-LEb 
domains have been unclear. Here we found that the p.R469Q, p.G699R, and p.R1078C variants affecting the 
LEa-LF-LEb domains found in isolated nephropathy cases did not abrogate laminin secretion but altered 
heparin and laminin-111 binding. These data suggest that the LEa-LF-LEb domains regulate matrix inter-
actions, and conformational changes in this segment lead to altered GBM structure. Because these variants 
do not cause extrarenal defects, the altered LEa-LF-LEb domains must maintain those laminin β2 functions 
required in ocular and neurological tissues. The present results suggest a novel mechanism underlying isolated 
nephropathy caused by LAMB2 defects, which is clinically and genetically distinct from Pierson syndrome.
The glomerular filtration barrier is permeable to water and small molecules and selectively restricts mac-
romolecules such as albumin (34). Because proteinuria precedes podocyte abnormalities in Lamb2-knock-
out mice, the GBM plays a critical role in selective filtration (29). The GBM had been believed to exhibit 
not only size selectivity but also charge selectivity to produce urine (31). However, because the reduction 
of  negative charge using knockout mice does not affect the filtration barrier (35, 36), the hypothesis of  
charge selectivity has been challenged (37). Therefore, the mechanism whereby laminin β2 influences the 
size selectivity of  the GBM is an important concept. In this study, WT laminin β2 bound heparin under 
not only low ionic but also acidic conditions, indicating that heparin binding is pH dependent. The pH 
dependency of  laminin β2 binding to heparin is likely due to the basic pI of  the β2 LN domain. The basic 
or neutral pI of  the β2 LN domain is conserved in the mouse and human (Supplemental Figure 4) whereas 
that of  the β1 LN domain is acidic. This may be why laminin β1 imperfectly compensates for the functions 
of  β2, despite their structural similarity (38). Our solid phase binding assays also showed that the laminin 
β2 variants, but not WT β2, bound to heparin under neutral conditions. The recombinant proteins carrying 
p.R469Q, p.G699R, and p.R1078C bound similarly to heparin. The binding of  mutant amino acid resi-
dues to heparin was minimal under physiologic conditions.
Figure 5. Characterization of laminin β2 chain. (A) Summary of isoelectric points (pI) of each domain of laminin β1 and β2 chains. (B) The extent of binding of 
heparin to laminin β1 and β2 short arms in 150 mM NaCl with 10 mM BisTris-HCl at pH = 6.1 or pH = 7.1, as indicated, was determined. Ninety-six-well microtiter 
plates were coated with the recombinant proteins at 10 μg/mL. After blocking, 10 μg/mL of biotinylated heparin was applied into the wells and incubated for 1 
hour at room temperature. The bound heparin was detected as described in Methods. Box-and-whisker plots show median, 25th and 75th percentiles, and mini-
mum and maximum values (n = 6 from 3 independent experiments). Data were analyzed by 1-way ANOVA with Tukey’s multiple-comparison test, *P < 0.001.
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The solid phase binding assay using truncated recombinant proteins showed that heparin binding sites 
are localized in the N-terminus of  β2. The variants may lead to a conformational change in the β2 short arm, 
causing heparin binding sites to become exposed. The heparin binding property of  laminin β2 allows us to 
hypothesize a model in which the short arm of  β2 variants binds to heparan sulfate on agrin in the GBM 
(Figure 8A). This binding seems to disturb laminin polymerization under physiologic conditions, resulting 
in a large-pore GBM that can be permeable to macromolecules such as albumin. Similar to the β2 variants, 
the WT β2 short arm binds to heparan sulfate under acidic conditions. To test this model, future investiga-
tions on the effect of  pH variation in mice would be required.
Once laminins are secreted into the extracellular space, they polymerize to form a meshwork via interac-
tions among LN domains of  the α, β, and γ short arms (33). The pairings of  α-α, α-β, α-γ, and β-γ are possible 
in the presence of  Ca2+ (39). Although the LN domain of  β2 binds to the N-termini of  α1, 2, 5; β1, 2; and γ1, 3, 
our solid phase binding assays showed that WT β2 short arm weakly bound to laminin-111. On the other 
hand, the mutant β2 short arms readily bound to laminin-111 in a calcium-independent manner. These in vitro 
results suggest a model in which the variants expose a cryptic laminin binding site in the β2 short arm under 
physiologic conditions. Structural or biochemical analyses using samples from patients or knock-in mice car-
rying these variants are required to confirm the model.
Our results indicate that laminin β2 serves as a potentially novel cell-adhesive ligand for integrin α4β1. 
Integrin α4β1 plays a major role in the regulation of  immune cell recruitment to inflamed endothelia and other 
Figure 6. Solid phase binding assays of mutant β2 short arm to immobilized laminin-111. (A) The binding of mutant 
laminin β2 short arm/Fc fusion proteins in 10 mM Tris-HCl (pH = 7.5), 150 mM NaCl, 1 mM CaCl2, and 1 mM MgCl2. Ninety-
six-well microtiter plates were coated with 10 μg/mL of EHS laminin-111. After blocking, the wells were incubated with 
10 μg/mL of recombinant proteins for 1 hour at room temperature. The bound recombinant proteins were detected 
with anti-human IgG Fc antibody. Box-and-whisker plots show median, 25th and 75th percentiles, and minimum and 
maximum values (n = 12 from 4 independent experiments). Data were analyzed by 1-way ANOVA with Tukey’s multi-
ple-comparison test, *P < 0.001. (B) Inhibitory effect of EDTA on the binding of mutant laminin β2 short arm/Fc fusion 
proteins to immobilized EHS laminin-111. The recombinant proteins were incubated in the presence of 10 mM EDTA. 
Data are shown as box-and-whisker plots (n = 9 from 3 independent experiments) with analysis by 1-way ANOVA with 
Tukey’s multiple-comparison test, *P < 0.001, **P < 0.05.
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sites of  inflammation. Previous studies have reported that integrin α4β1 is a receptor for vascular cell adhesion 
molecule-1 (VCAM-1) and fibronectin (40). In fibronectin, integrin α4β1 recognizes a motif  containing the 
sequence EILDVPST within the alternatively spliced connecting segment-1 (41), with the LDV sequence 
being most critical (42). Homology search of  the rat laminin β2 amino acid sequence revealed that 2 LDVs 
Figure 7. Analysis of cell adhesion to laminin β2. (A) Adhesion of HEK293 cells to the WT β2 short arm in diluted DMEM. 
Ninety-six-well microtiter plates were coated with 10 μg/mL of Fc (control tag protein), B1SA_Fc (β1 short arm), B1LN-
LEa_Fc (β1 LN-LEa domains), B2SA_Fc (β2 short arm), and B2LN-LEa_Fc (β2 LN-LEa domains). After blocking, HEK293 cells 
were suspended in DMEM diluted with H2O and incubated in the wells at 37°C for 30 minutes. Attached cells were stained 
with Diff-Quik and counted. Box-and-whisker plots show median, 25th and 75th percentiles, and minimum and maximum 
values (n = 6 from 3 independent experiments). Data were analyzed by 1-way ANOVA with Tukey’s multiple-comparison 
test, *P < 0.001. (B) Adhesion of HEK293 cells to the mutant β2 short arms in the 1:3 DMEM dilution. Ninety-six-well 
microtiter plates were coated with 20 μg/mL of the mutant recombinant proteins. The number of attached cells is shown 
as box-and-whisker plots (n = 6 from 3 independent experiments) with analysis by 1-way ANOVA with Tukey’s multi-
ple-comparison test, *P < 0.001. (C) Inhibitory effects of integrin-blocking antibodies on adhesion of HEK293 cells to β2 
LN-LEa domains. HEK293 cells preincubated with function-blocking antibodies against the indicated integrin subunits 
were added to B2LN-LEa_Fc–coated wells. After incubation for 30 minutes, the attached cells were stained and counted. 
The attached cells were quantified and analyzed as described above. Data are shown as box-and-whisker plots (n = 6 from 
3 independent experiments) with analysis by 1-way ANOVA with Tukey’s multiple-comparison test, *P < 0.001.
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are localized in the LN and LCC domains, respectively. The N-terminal LDV sequence is likely exposed to 
integrin α4β1 because the position is close to the signal peptide cleavage site. However, this LDV is conserved 
in rodents but not humans. We also searched for the LDV sequence in human laminin β2 and found that it is 
localized in the LF domain. This LDV is conserved in mammals except for rodents. Pulido et al. reported the 
Figure 8. Schematic of laminin β2 activity in the GBM. (A) The disorder of permselectivity on GBM with β2 variants. The 
polymerization of laminin-521 containing WT β2 chain forms the GBM that restricts permeability of macromolecules such 
as albumin (ALB) (left). The N-terminus of β2 variants binds to heparan sulfates on agrin, when the LEa-LF-LEb variants 
are present (right). This binding disturbs laminin polymerization, resulting in larger GBM pores with increased perme-
ability to albumin. (B) Dysfunction of GBM with laminin β2 variants. The heparin-binding activity of laminin β2 variants 
leads to a large-pore GBM under neutral conditions, resulting in proteinuria. Increased laminin binding also results in the 
accumulation of β2 variants in the GBM. The increased cell adhesive activity would affect glomerular cells.
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crystal structure of  the laminin β2 LF domain (43). Because the position of  the LDV is located at the molecu-
lar surface, integrin α4β1 would be able to bind to the sequence. Our recent study showed that the β2 short arms 
are polymerized toward the center of  the GBM, suggesting that it is difficult for the binding site to be accessi-
ble to integrins (32). The excessive deposition of  β2 variants in the GBM may expose adhesive sites for integrin 
α4β1–positive cells (Figure 8B). In this regard, expression of  integrin α4β1 was detected in the endothelial cells 
and mesangial cells of  glomeruli (Supplemental Figure 5). Therefore, the exposure of  the integrin binding site 
might strengthen cell adhesion, leading to glomerular dysfunction. Integrin α4β1 is a major cell surface recep-
tor on immune cells such as lymphocytes. Moreover, Jurkat and Raji cells derived from human lymphocytes 
adhere to laminin β2 via integrin α4β1 (data not shown). The nephritogenic immune responses are driven by 
CD4+ T cells (44). CD4+ T cells spontaneously adhere within uninflamed glomerular capillaries (45), and 
the accumulation of  immune cells such as CD4+ T cells, neutrophils, and macrophages is often observed in 
inflamed glomeruli (44). In addition to VCAM-1 on glomerular endothelial cells, laminin β2 may also serve as 
an adhesive ligand for inflammatory cells in nephritis.
Increased laminin deposition in the GBM has been reported in a Col4a3–/– mouse model of Alport syndrome 
(46, 47). LAMB1 and LAMA2 are normally found in the mesangial matrix, but ectopic deposition is detected 
in Alport GBM (46). Furthermore, increased laminin α5 mRNA was detected in Alport glomeruli (47). The 
increased deposition of laminin was also reported in patients with Alport syndrome (48). These increases may be 
due to increased production or altered turnover of extracellular matrix molecules triggered by instability caused 
by the collagen abnormality. We hypothesize that the mechanism of GBM laminin anomalies observed in Alport 
syndrome is different from that predicted here due to variations in the LEa-LF-LEb domains of LAMB2.
The variants in the LEa-LF-LEb domains found in isolated nephropathy are not common, but the allele 
frequencies of  some variants are around 1% in specific ethnic populations. For example, the frequency of  
c.2095G>C (p.G699R; rs28364667) is 0.012 in the East Asian population and 0.007 in Japanese databases. 
Variant c.3071C>T (p.P1024L; rs368506627) is observed at 0.0098 in the South Asian population (gnomAD, 
ref. 20). Many Mendelian disorders, such as Pierson syndrome, are caused by highly penetrant rare variants. 
Recent empirical evidence has shown that variants at low frequency or rare variants are associated with com-
plex diseases. The recessive nature of  these variants and the residual function of  the mutant proteins make 
it difficult to determine their pathogenicity. Mouse models with altered LEa-LF-LEb domains to mimic the 
defect or exome- or whole genome–based variant analysis in large cohorts, including several target popu-
lations, will be required to further uncover the contribution of  disease-related variants in this region to the 
pathogenesis of  proteinuric kidney disease.
Methods
Antibodies and regents. Monoclonal antibodies against human integrin α2 (P1E6), α3 (P1B5), α4 (P4G9), α5 (P1D6), 
α6 (P5G10), and αV (P3G8) (Developmental Studies Hybridoma Bank) were purified on Protein G Sepharose 
(Cytiva) from conditioned media of hybridoma cells purchased from Developmental Studies Hybridoma Bank. 
Anti–integrin α1 (FB12), β1 (6S6), and β3 (25E11) antibodies were purchased from Merck. Anti–β-actin antibody 
conjugated with peroxidase was from Medical & Biological Laboratories Co. Ltd. Alexa Fluor 647–conjugated 
rat monoclonal antibody against mouse integrin α4 (R1-2) and isotype control rat IgG2bκ (RTK4530) were 
purchased from BioLegend. Anti-podocin polyclonal antibody (catalog ab50339) was from Abcam. Human 
recombinant laminin-111 (LM111), laminin-511 (LM511), and laminin-521 (LM521) were purchased from 
BioLamina. Mouse EHS laminin was from BD Biosciences and Takako Sasaki (Oita University School of Med-
icine, Oita, Japan). Biotinylated heparin with an average mass of 12.5 kDa was from Celsus Laboratories, Inc.
Construction of  expression vectors. cDNA clones encoding full-length mouse laminin β1 (provided by Albert 
E. Chung, University of  Pittsburgh, Pittsburgh, Pennsylvania) and rat laminin β2 (generated in-house) were 
used to construct expression vectors. The fragments encoding laminin β1 LN-LEa domains (B1N) and 
short arm (B1SA) were amplified using primer sets described in Supplemental Table 3 and subcloned into 
a human IgG1 Fc expression vector. The EcoRI-XbaI fragment encoding the laminin β2 LN-LEa domains 
(B2N) was subcloned into a human IgG1 Fc expression vector. To construct the β2 short arm expression vec-
tor, the fragment encoding laminin β2 LF-LEb domains was amplified using primer sets described in Supple-
mental Table 3 and subcloned into the XbaI site of  the B2N_Fc expression vector. The R469Q, G699R, and 
R1078C human laminin β2 variants were separately engineered into analogous sites of  the rat cDNA by site 
directed mutant PCR using primer sets described in Supplemental Table 3. Laminin β2 carrying the C321R 
variant was prepared in our previous study (28).
1 3
R E S E A R C H  A R T I C L E
JCI Insight 2021;6(6):e145908  https://doi.org/10.1172/jci.insight.145908
Preparation of  serum-free conditioned media and cell lysates. HEK293 cells were obtained from the American 
Type Culture Collection. The cells were maintained in DMEM containing 10% fetal calf  serum. To express 
WT and mutant proteins, the expression vectors were transiently transfected into the cells in 24-well plates 
using Lipofectamine 2000 (Thermo Fisher Scientific). The next day, the growth media were replaced with 
500 μL of serum-free medium. After 3 days’ culture, the conditioned media were harvested and clarified by 
centrifugation twice at 100g for 5 minutes and 9730g for 10 minutes. Then 20 μL of conditioned media were 
applied for immunoblotting. The transfectants were also lysed with 500 μL of 10 mM Tris-HCl (pH 7.5), 150 
mM NaCl, 10 mM EDTA, 1% NP-40, and protease inhibitor cocktail (Merck). The cell lysates were clarified 
by centrifugation once at 9730g for 10 minutes. Then 20 μL of cell lysate was applied for immunoblotting.
Immunoblotting. Cell lysates and conditioned media were separated on 5%–20% gradient gels (ATTO) 
under reducing conditions and transferred to a PVDF membrane (Merck). Conditioned media and 
lysates were immunoblotted with anti-human IgG1 Fc antibody (Jackson ImmunoResearch catalog 109-066-
098). The bound antibodies were visualized with the ECL Western blotting detection system (Cytiva). The imag-
es of bands were captured with WSE-6100 Lumino Graph I (ATTO).
Expression and purification of  recombinant proteins. HEK293 cells transfected with the expression vectors 
were selected using 100 μg/mL Zeocin (Thermo Fisher Scientific). All further cell culture was carried out 
in the presence of  the antibiotic. The selected cells were grown to confluence in culture dishes with DMEM 
containing 10% FBS. The confluent cells were incubated in serum-free DMEM for 4 days. The conditioned 
media were harvested and clarified by centrifugation twice at 100g for 5 minutes and 9730g for 10 minutes. 
The recombinant proteins were purified from the conditioned culture media by Protein A Sepharose (Cyti-
va). The eluted fractions were pooled and dialyzed against PBS(-). The purified proteins were separated 
by SDS-PAGE using 5%–20% gels under reducing conditions. The separated proteins were stained with 
Coomassie Brilliant Blue (nacalai tesque).
Solid phase binding assays. Heparin binding assays were carried out with recombinant proteins coated 
onto high-protein-binding capacity 96-well microtiter plates (IWAKI). The plates were blocked with PBS(-) 
containing 1% BSA for 1 hour at room temperature. A total of  10 μg/mL of  biotinylated heparin in 10 mM 
Tris-HCl (pH 7.5) containing 0, 150, and 500 mM NaCl or 10 mM BisTris-HCl (pH 6.1 and 7.1) containing 
150 mM NaCl was added into the wells. After incubation for 1 hour at room temperature, the bound heparin 
was detected by addition of  streptavidin-conjugated horseradish peroxidase, followed by addition of  1 mg/
mL o-phenylenediamine and 0.012% H2O2. The absorbance was measured at 450 nm with Multiskan GO 
microplate spectrophotometer (Thermo Fisher Scientific). For laminin-111 binding assay, 96-well microtiter 
plates were coated with 10 μg/mL of  EHS laminin-111. After blocking with PBS(-) containing 1% BSA, 10 
μg/mL of  Fc-tagged recombinant proteins in the binding buffer (10 mM Tris-HCl pH 7.5, 150 mM NaCl, 
1 mM CaCl2, 1 mM MgCl2 containing 0.05% Tween 20) were incubated at room temperature for 1 hour. 
The bound recombinant proteins were detected with a biotinylated anti-human IgG Fc antibody (Jackson 
ImmunoResearch) and quantified as described above.
Cell attachment assays. For adhesion assays, 96-well microtiter plates (IWAKI) were coated with recom-
binant proteins and blocked with PBS(-) containing 1% BSA. The dissociated HEK293 cells were suspend-
ed in serum-free DMEM and plated at 2 × 104 cells/50 μL/well. After incubation at 37°C for 0.5 or 1 hour, 
the attached cells were stained with Diff-Quik (SYSMEX). The stained cells were counted using image 
cytometer BZ-X800 (Keyence). To identify the receptors for laminin β2, 10 μg/mL of  monoclonal antibod-
ies against different integrins were preincubated individually with cells in a volume of  50 μL of  serum-free 
medium (2 × 104 cells/well) at room temperature for 10 minutes. The preincubated cells were transferred to 
plates coated with laminin β2 LN-LEa domains fused with Fc-tag (B2N_Fc) and then incubated further at 
37°C for 1 hour. After incubation, the attached cells were quantified as described above.
Staining of  renal biopsy specimens. Kidney biopsy specimens were fixed in 10% neutral buffered formalin 
and embedded in paraffin. The tissues were sectioned and stained with periodic acid–methenamine silver 
stain–Masson’s trichrome and periodic acid–Schiff.
Electron microscopy. After fixation in glutaraldehyde fixative (1.6% v/v paraformaldehyde, 2.5% v/v glu-
taraldehyde, 0.2 M sodium cacodylate buffer pH 7.4, 5 mM CaCl2, 10 mM MgCl2), tissues were embedded 
in epon resin and sectioned. Imaging was performed using a HITACHI H-7100.
Immunohistochemistry. C57BL/6J mice (72 weeks old, male) were purchased from Charles River Labora-
tories Japan. Mice were sacrificed under deep anesthesia with Thiopental. Mouse kidneys were frozen in Tis-
sue-Tek optimum cutting temperature compound (Sakura Finetek) and were cut at 7 μm in a cryostat. After 
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blocking with 10% normal goat serum, the sections were incubated with rat monoclonal antibody against 
mouse integrin α4 and rabbit polyclonal antibody against podocin. The integrin α4 antibody conjugated with 
Alexa Fluor 647 was used. Rabbit IgG was detected with secondary antibody conjugated with Alexa Fluor 
594 (Thermo Fisher Scientific catalog A11037). After several washes, sections were mounted in 90% glycerol 
containing 0.1× PBS and 1 mg/mL p-phenylenediamine. Images were captured using a BZ-X800 (Keyence).
Statistics. Comparisons between groups were analyzed using 1-way ANOVA with Tukey’s multiple-com-
parison test. Statistical analyses were performed in R Studio (Version 1.3.1093). Significance, set at P < 0.05, is 
depicted as follows in figures: *P < 0.001, **P < 0.05.
Study approval. Informed consent was obtained from all the members of  a family according to the guide-
lines of  the Ethics Committee of  Yamagata University (protocol number 2018-190) and the University of  
New Mexico School of  Medicine. Clinical data of  patients, including laboratory data, imaging data, and kid-
ney biopsy, were obtained for diagnostic purposes and with informed consent. Animal studies were approved 
by the Animal Research Committee of  Tokyo University of  Pharmacy and Life Sciences (P20-33).
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